# First Capital Inc: Form 10-Q for the period ended Mar 31, 2024

- Company: [First Capital Inc](/companies/fcap.md) (CIK 1070296)
- Form: 10-Q
- Filed: 2024-05-14
- Accepted by EDGAR: May 14, 2024, 16:31 ET
- Period: 2024-03-31
- Accession: 0001171843-24-002868
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070296/000117184324002868/fcap20240331_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070296/000117184324002868/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-01-01 to 2024-03-31 | $1.7m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Operating income | 3 months, 2024-01-01 to 2024-03-31 | $3.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2024-01-01 to 2024-03-31 | $3.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2024-01-01 to 2024-03-31 | $507.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-01-01 to 2024-03-31 | $3.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-01-01 to 2024-03-31 | $0.88 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-01-01 to 2024-03-31 | $0.88 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-01-01 to 2024-03-31 | 3,345,060 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2024-01-01 to 2024-03-31 | $7.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2024-01-01 to 2024-03-31 | $159.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2024-01-01 to 2024-03-31 | $905.0k | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2024-01-01 to 2024-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | at 2024-03-31 | $1.16bn | us-gaap:Assets |
| Total liabilities | at 2024-03-31 | $1.05bn | us-gaap:Liabilities |
| Shareholders' equity | at 2024-03-31 | $105.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 432 characters.

On August 19, 2008, the board of directors authorized the repurchase of up to 240,467 shares of the Company’s outstanding common stock. The stock repurchase program will expire upon the purchase of the maximum number of shares authorized under the program, unless the board of directors terminates the program earlier. There were no repurchases of the Company’s outstanding common stock during the three months ended March 31, 2024.

## Risk factors

As filed, 188 characters.

There have been no material changes to the risk factors previously disclosed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Filed May 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-002868. Last ingested by Listed: Nov 13, 2026, 16:19 ET. No prices; not investment advice.
